or
forgot password

    • cancer clinical trials in des moines, IA

    • Carboplatin, Paclitaxel, and Bevacizumab With or Without Everolimus in Treating Patients With Metastatic Malignant Melanoma
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Des Moines, Iowa 50314
    Melanoma (Skin)
    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Iowa Methodist Medical Center

    Trial Locations
    Iowa Methodist Medical Center
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Carcinoma, Stage IV Endometrial Carcinoma
    Glutathione in Preventing Peripheral Neuropathy Caused by Paclitaxel and Carboplatin in Patients With Ovarian Cancer, Fallopian Tube Cancer, and/or Primary Peritoneal Cancer
    John Stoddard Cancer Center at Iowa Methodist Medical Center

    Trial Locations
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Chemotherapeutic Agent Toxicity, Fallopian Tube Cancer, Neurotoxicity, Ovarian Cancer, Pain, Peripheral Neuropathy, Primary Peritoneal Cavity Cancer
    Belinostat and Carboplatin in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Carboplatin or Cisplatin
    Iowa Lutheran Hospital

    Trial Locations
    Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    Study of Tissue and Blood Samples From Patients With Low-Grade Glioma
    John Stoddard Cancer Center at Iowa Methodist Medical Center

    Trial Locations
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Brain and Central Nervous System Tumors
    Lisinopril or Coreg CR® in Reducing Side Effects in Women With Breast Cancer Receiving Trastuzumab
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Des Moines, Iowa 50314
    Breast Cancer, Cardiac Toxicity
    Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery
    CCOP - Iowa Oncology Research Association

    Trial Locations
    CCOP - Iowa Oncology Research Association
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Colorectal Cancer, Precancerous Condition
    Selumetinib in Treating Patients With Recurrent or Persistent Endometrial Cancer
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Recurrent Endometrial Carcinoma
    Gemcitabine Hydrochloride and Docetaxel With or Without Bevacizumab in Treating Patients With Advanced or Recurrent Uterine Leiomyosarcoma
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Recurrent Uterine Sarcoma, Stage IIIA Uterine Sarcoma, Stage IIIB Uterine Sarcoma, Stage IIIC Uterine Sarcoma, Stage IVA Uterine Sarcoma, Stage IVB Uterine Sarcoma, Uterine Leiomyosarcoma
    Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed By the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed By Surgery
    Medical Oncology and Hematology Associates

    Trial Locations
    Medical Oncology and Hematology Associates
    Iowa Oncology Research Association CCOP
    Mercy Medical Center - Des Moines
    Medical Oncology and Hematology Associates-Des Moines
    Adenocarcinoma of the Pancreas, Stage I Pancreatic Cancer, Stage II Pancreatic Cancer
    Seneca Valley Virus-001 After Chemotherapy in Treating Patients With Extensive-Stage Small Cell Lung Cancer
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Lung Cancer
    AMG 102 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer
    John Stoddard Cancer Center at Iowa Methodist Medical Center

    Trial Locations
    John Stoddard Cancer Center at Iowa Methodist Medical Center
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Fallopian Tube Cancer, Ovarian Cancer, Malignant Tumor of Peritoneum
    Gemcitabine Hydrochloride or Pemetrexed Disodium and Carboplatin With or Without Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
    John Stoddard Cancer Center at Iowa Lutheran Hospital

    Trial Locations
    John Stoddard Cancer Center at Iowa Lutheran Hospital
    Medical Oncology and Hematology Associates at John Stoddard Cancer Center
    Medical Oncology and Hematology Associates at Mercy Cancer Center
    Mercy Cancer Center at Mercy Medical Center - Des Moines
    Lung Cancer